-
Genome and transcriptome sequence data from an alveolar soft part sarcoma patient
Dataset
EGAD00001005909
-
Genome and transcriptome sequence data from a gastroesophageal junction adenocarcinoma patient
Dataset
EGAD00001005910
-
Genome and transcriptome sequence data from a colon adenocarcinoma patient
Dataset
EGAD00001005911
-
Genome and transcriptome sequence data from an osteosarcoma patient
Dataset
EGAD00001005913
-
Genome and transcriptome sequence data from a squamous cell carcinoma patient
Dataset
EGAD00001005908
-
Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient
Dataset
EGAD00001005907
-
Genome and transcriptome sequence data from a colorectal adenocarcinoma patient
Dataset
EGAD00001005881
-
Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient
Dataset
EGAD00001005882
-
Genome and transcriptome sequence data from a malignant choroid melanoma patient
Dataset
EGAD00001005883
-
Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient
Dataset
EGAD00001005884
-
Genome and transcriptome sequence data from a colorectal adenocarcinoma patient
Dataset
EGAD00001005886
-
Genome and transcriptome sequence data from a parotid gland adenoid cystic carcinoma patient
Dataset
EGAD00001005887
-
Genome and transcriptome sequence data from a breast carcinoma patient
Dataset
EGAD00001005888
-
Genome and transcriptome sequence data from a pancreatic ductal adenocarcinoma patient
Dataset
EGAD00001005889
-
Genome and transcriptome sequence data from a melanoma patient
Dataset
EGAD00001005890
-
Genome and transcriptome sequence data from a thyroid hurthle cell carcinoma patient
Dataset
EGAD00001005891
-
Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient
Dataset
EGAD00001005892
-
Genome and transcriptome sequence data from a ewing sarcoma patient
Dataset
EGAD00001005894
-
Genome and transcriptome sequence data from a cecum adenocarcinoma patient
Dataset
EGAD00001005895
-
Genome and transcriptome sequence data from an endometrial stromal sarcoma patient
Dataset
EGAD00001005899
-
Genome and transcriptome sequence data from a hemangioma patient
Dataset
EGAD00001005900
-
Genome and transcriptome sequence data from a pancreatic ductal adenocarcinoma patient
Dataset
EGAD00001005901
-
Genome and transcriptome sequence data from a metastatic gallbladder adenocarcinoma patient
Dataset
EGAD00001005903
-
Genome and transcriptome sequence data from a pancreatic ductal adenocarcinoma patient
Dataset
EGAD00001005904
-
Genome and transcriptome sequence data from an adenocarcinoma patient
Dataset
EGAD00001005905
-
Genome and transcriptome sequence data from a metastatic clear cell carcinoma of the ovary patient
Dataset
EGAD00001005906
-
Dataset of whole-exome sequencing of extranodal NK/T cell lymphoma
Dataset
EGAD00001006062
-
Whole-exome sequences of ovarian clear cell carcinomas and paired normal DNA
Dataset
EGAD00001006004
-
Blood plasma and paired genomic DNA from neuroblastoma patients
Dataset
EGAD00001006012
-
Single cell sequencing of a post-PD-1 inhibitor metastatic melanoma mass
Dataset
EGAD00001006013
-
Mixing Sample Low Grade Glioma Gender Male, Age , 34,44
Dataset
EGAD00001006018
-
SF12199 Primary diffuse astrocytoma G3
Dataset
EGAD00001006020
-
European Roma whole genomes sequences
Dataset
EGAD00001006024
-
MCL NGS data
Dataset
EGAD00001006025
-
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma -- CA209-010
Dataset
EGAD00001006026
-
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma -- CA209-009
Dataset
EGAD00001006027
-
Multiregional non-invasive genetic characterization of MM
Dataset
EGAD00001006028
-
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma -- CA209-025
Dataset
EGAD00001006029
-
Exome sequencing of women with familial high-grade serous ovarian carcinoma
Dataset
EGAD00001006030
-
Sequencing of uveal melanoma metastases
Dataset
EGAD00001006031
-
PFA ependymoma study -WGS data
Dataset
EGAD00001006045
-
PFA ependymoma study -RNA-seq data
Dataset
EGAD00001006046
-
Exome sequences of AL amyloidosis (ALA), multiple myeloma (MM) and ALA+MM hematological malignancies
Dataset
EGAD00001006047
-
Distribution of ctDNA levels in plasma of early-stage non-small cell lung cancer patients measured using personalised ctDNA analysis
Dataset
EGAD00001006230
-
Phenotypic characterisation of LRRN4CL over-expression
Dataset
EGAD00001006249
-
NABUCCO cohort 1 (NCT03387761) - Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy
Dataset
EGAD00001006250
-
multi regional whole exome sequencing of gastric adenocarcinoma
Dataset
EGAD00001006251
-
Convergent somatic mutations in effectors of insulin signalling in chronic liver disease
Dataset
EGAD00001006255
-
Melanoma transcriptome profiling
Dataset
EGAD00001006270
-
RNAseq BAM files
Dataset
EGAD00001006268
-
Melanoma exome profiling
Dataset
EGAD00001006271
-
Melanoma microRNA profiling
Dataset
EGAD00001006269
-
Raw microarray gene expression data from NPC samples_Cohort 1
Dataset
EGAD00001006273
-
Raw microarray gene expression data from NPC samples_Cohort 2
Dataset
EGAD00001006272
-
Processed microarray gene expression data from NPC samples_Cohort 2
Dataset
EGAD00001006274
-
Processed microarray gene expression data from NPC samples_Cohort 1
Dataset
EGAD00001006275
-
Single cell transcriptomes of of primary tumors and normal endometrial derived organoids treated with DBZ
Dataset
EGAD00001006280
-
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
Dataset
EGAD00001006281
-
Conserved interferon-gamma signaling and decreased immune exclusion programs in responses to immune checkpoint blockade therapy_CM38-RNA
Dataset
EGAD00001006282
-
Conserved interferon-gamma signaling and decreased immune exclusion programs in responses to immune checkpoint blockade therapy_CM38-DNA
Dataset
EGAD00001006284
-
Single-cell RNA sequencing for metastatic gastric adenocarcinoma
Dataset
EGAD00001006172
-
RNA-seq of pcALCL
Dataset
EGAD00001006178
-
WGS of pcALCL
Dataset
EGAD00001006176
-
WES of pcALCL
Dataset
EGAD00001006177
-
WGS,RNA data of patients with multiple myeloma (MM) refractory to immunomodulatory agents (IMiDs) and proteasome inhibitors (PIs)
Dataset
EGAD00001006189
-
A Single-Cell Atlas of the Multicellular Ecosystem of Primary and Metastatic Hepatocellular Carcinoma
Dataset
EGAD00001006190
-
Competitive selection of somatic mutant clones in normal human skin varies with body site
Dataset
EGAD00001006194
-
Glioblastoma stem cell lines RNA-seq data
Dataset
EGAD00001006195
-
Additional Neuroblastoma whole genome sequencing data
Dataset
EGAD00001006196
-
Processed RNA-seq data for clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Dataset
EGAD00001006199
-
Phenotype data for clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Dataset
EGAD00001006200
-
Genotype data for clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Dataset
EGAD00001006201
-
Pediatric Glioblastoma with Persistent STAG2 Mutation
Dataset
EGAD00001006202
-
Raw RNA-seq data for clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Dataset
EGAD00001006205
-
Single-cell RNA-sequencing reveals that glioblastoma recapitulates a normal neurodevetlopmental hierarchy
Dataset
EGAD00001006206
-
Merged single-cell RNA-seq data for 22 Hodgkin lymphomas and 5 reactive lymph nodes
Dataset
EGAD00001006221
-
Identification of gene mutations and fusion genes in patients with Sézary Syndrome
Study
EGAS00001001706
-
Prognostic relevance of microenvironmental factors CD163 and CD8 combined with EZH2 and chromosome 18 gain in a validation cohort of follicular lymphoma patients of the Lunenburg Lymphoma Biomarker Consortium
Study
EGAS00001002049
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__clear_cell_renal_cell_carcinoma
Study
EGAS00001002608
-
Preferential infiltration of distinct Vγ9δ2 T cells into Glioblastoma multiforme
Study
EGAS00001002790
-
Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations
Study
EGAS00001003931
-
Lindsey E. Jones et al. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neuro-Oncology Advances, 2020. We established robust, versatile, and well-characterized Patient Derived Cells (PDC) of an IDH1-mutant astrocytoma and an IDH1-mutant oligodendroglioma that represents defined evolutionary stages of chemotherapy-induced hypermutation. The PDCs retain tumor subtype defining features over time as well as classic hallmarks of cancer, including anchorage independent growth and cell immortality. The integrated phylogenies composed of PDCs,single-cell-derived PDCs, patient-derived xenografts, and corresponding spatiotemporal tumor tissue samples also provide new insight into the clonality, evolutionary pattern, and immense mutational load of hypermutated IDH mutant gliomas.
Study
EGAS00001003992
-
The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH
Study
EGAS00001004285
-
Clinical relevance of somatic copy-number alterations in plasma circulating tumor DNA from advanced EGFR-mutated NSCLC patients treated with osimertinib
Study
EGAS00001004539
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – Whole exome sequencing
Study
EGAS00001004832
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – RNA sequencing
Study
EGAS00001004833
-
Assessment of cannabidiol and Δ9-tetrahydrocannabiol in mouse models of medulloblastoma
Study
EGAS00001004963
-
Molecular characterization of Barrett’s esophagus at single cell resolution
Study
EGAS00001005221
-
Sequential single-cell transcriptional and protein marker profiling reveals TIGIT as a marker of CD19 CAR-T cell dysfunction in patients with non-Hodgkin’s lymphoma
Study
EGAS00001005356
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001005738
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001005747
-
Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma
Study
EGAS00001006986
-
Combination of ribociclib and gemcitabine for the treatment of medulloblastoma
Study
EGAS00001006001
-
early-stage ESCC sequencing study
Study
EGAS00001006126
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001006142
-
Multi-organ landscape of therapy-resistant melanoma
Study
EGAS00001006644
-
RNA-seq of DF149 cells – a patient-derived xenograft model of ascites-derived, homologous recombination repair-proficient, high-grade serous ovarian carcinoma – cultured in vitro and isolated after 8 hours treatment with DMSO control (3 x biological replicates) and 2.5 µM CBL0137 (3 x biological replicates)
Study
EGAS00001006662
-
NanoString nCounter® PanCancer IO 360™on anti-PD1/anti-PD1+CTLA4 in patients with metastatic melanoma
Study
EGAS00001006977
-
An IL-1β driven neutrophil-stromal cell axis fosters a BAFF-rich microenvironment in multiple myeloma
Study
EGAS00001007038
-
ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA
Study
EGAS00001007077